A surrogate barrier model for high-throughput blood-brain barrier permeability prediction: integrating LLC-PK1-MOCK/MDR1 Cells and lysosomal trapping correction
To mitigate risks in central nervous system (CNS) drug development, we established a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cells in a Transwell system, aiming to replicate in vivo brain distribution and elucidate permeability mechanisms. Model i...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2025-12-01
|
| Schriftenreihe: | Drug Delivery |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/10717544.2025.2585612 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
